Tina Milos, David Rojo, Gordana Nedic Erjavec, Marcela Konjevod, Lucija Tudor, Barbara Vuic, Dubravka Svob Strac, Suzana Uzun, Ninoslav Mimica, Oliver Kozumplik, Coral Barbas, Neven Zarkovic, Nela Pivac, Matea Nikolac Perkovic
Alzheimer's disease (AD) is often not recognized or is diagnosed very late, which significantly reduces the effectiveness of available pharmacological treatments. Metabolomic analyzes have great potential for improving existing knowledge about the pathogenesis and etiology of AD and represent a novel approach towards discovering biomarkers that could be used for diagnosis, prognosis, and therapy monitoring. In this study, we applied the untargeted metabolomic approach to investigate the changes in biochemical pathways related to AD pathology...
July 16, 2023: Progress in Neuro-psychopharmacology & Biological Psychiatry